Horizon Therapeutics plc to Participate in Upcoming Investor Conferences
November 25 2020 - 8:00AM
Business Wire
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the
Company will participate in the following conferences in
December:
2020 Evercore ISI HealthCONx Conference
- Presentation Time: 9:15 a.m. ET
Piper Sandler 32nd Annual Virtual Healthcare
Conference
- Presentation Time: 1:30 p.m. ET
BMO 2020 Growth & ESG Conference
- Date: Tues., Dec. 8, 2020
- Presentation Time: 1:00 p.m. ET
The conference presentations will be webcast live and may be
accessed by visiting Horizon's website at
http://ir.horizontherapeutics.com. A replay of the webcasts will be
available following each event.
About Horizon
Horizon is focused on researching, developing and
commercializing medicines that address critical needs for people
impacted by rare and rheumatic diseases. Our pipeline is
purposeful: we apply scientific expertise and courage to bring
clinically meaningful therapies to patients. We believe science and
compassion must work together to transform lives. For more
information on how we go to incredible lengths to impact lives,
please visit www.horizontherapeutics.com and follow us on Twitter,
LinkedIn, Instagram and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201125005407/en/
Investors: Tina Ventura Senior Vice President, Investor
Relations investor-relations@horizontherapeutics.com Ruth Venning
Executive Director, Investor Relations
investor-relations@horizontherapeutics.com U.S. Media: Geoff
Curtis Executive Vice President, Corporate Affairs & Chief
Communications Officer media@horizontherapeutics.com Ireland
Media: Ray Gordon Gordon MRM ray@gordonmrm.ie
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Sep 2023 to Sep 2024